secwatch.observer — SEC 8-K summary
======================================

Issuer:     P3 Health Partners Inc. (PIII)
CIK:        0001832511
Form:       8-K
Filed at:   2023-03-31T23:59:59+00:00
Accession:  0001104659-23-039608
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

P3 Health Partners Q4 2022 net loss $532.3M on $463.5M goodwill impairment; revenue up 40%
--------------------------------------------------------------------------------

- Q4 capitated revenue $254.0M (+40% YoY); net loss $532.3M vs $118.2M loss, primarily due to $463.5M goodwill impairment.
- Adjusted EBITDA loss $40.1M vs $35.6M; Adjusted EBITDA PMPM loss improved to $133 from $177 in Q4 2021.
- Full-year 2022 network contribution improved 65% vs 2021; company affirms 2023 guidance, expects Adjusted EBITDA positive in early 2024.
- Introduced year-end medical margin guidance as new non-GAAP metric.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832511/000110465923039608/0001104659-23-039608-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832511/000110465923039608/tm2311097d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-039608

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer